Browsing: Pharma

In the past seven months, Boehringer Ingelheim has won approval and label extensions in the…

South Korea’s Arteogen ensnared another big pharma partner, Biogen, after luring GSK, which topped this…

Takeda Pharmaceutical is preparing for a new radical restructuring aimed at streamlining operations to fund…

Karyopharm’s Expovio has stalled in the clinic and market after gaining approval for the treatment…

Despite recent policy uncertainties, Wuxi Biologics’ focus on its US operations will continue to pay…

Eli Lilly is scaling back the rollout of its traditional insulin in Europe, with plans…

A high-profile drug fraud case that could potentially throw the pharmaceutical industry into the legal…

Major pharmaceutical companies, with sales of at least $20 billion in 2025, cut a total…

Gilead is increasing Chief Executive Officer Daniel O’Day’s compensation by 20% to $28.4 million in…

A new warning about a common combination drug for Parkinson’s disease is needed after the…